Skip to main content
Equibles
RXRX logo

RXRX · Recursion Pharmaceuticals, Inc. · Analyst Estimates

Track RXRX — free

Use RXRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RXRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.16 -0.05 (-1.70%) At close · Sep 10
Russell 2000 member Rebalance outlook locked
Market Cap
$1.72B
Shares
535.34M

Analyst Estimates

Compare analyst forecasts for Recursion Pharmaceuticals, Inc. across metrics and forecast periods.

Low, average and high estimates appear together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 157 filings 157 filers Visit website Investor relations